1. Home
  2. CYBN

CYBN

Cybin Inc.

Logo Cybin Inc.

Health Care

Pharmaceuticals and Biotechnology

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Founded: 2019 Country:
N/A
Employees: N/A City: N/A
Market Cap: 279.4M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 5.5M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.20 EPS Growth: N/A
52 Week Low/High: $0.21 - $0.74 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: